Company enters the psoriasis and vitiligo market in India with a population of 1.4 billion
JUPITER, FL / ACCESSWIRE / Nov 4, 2022 / Jupiter WellnessInc. (Nasdaq:JUPW), a wellness company focused on hair loss, eczema, burns and sexual wellness, today announced that its Photocil product (branded as PhotoFirst in India) has been approved by the CDSCO for sale in India. The Central Drug Standards Control Organization (CDSCO), under the Directorate General of Health Services, Ministry of Health and Family Welfare, is the National Regulatory Authority (NRA) of India.
Photocil is a topical product that filters the sun’s UV rays to allow only the therapeutic UV spectrum to penetrate the skin. It is used for the treatment of psoriasis and vitiligo.
Immediately following this announcement, Jupiter Wellness scientific team members will travel to India to meet with partners from ErisOaknet Healthcare, an Indian pharmaceutical company, and to present at an upcoming international speaker program in Mumbai on November 12, 2022.
The International Speakers Program focuses on redefining phototherapy in autoimmune skin diseases. The event will feature presentations from Dr. Glynn Wilson, Scientific Director of Jupiter Wellness, and Prof. Dr. Andy Goren, the inventor of Photocil.
In the second quarter of 2022, Sanpellegrino Cosmetics Pvt Ltd and Cosmofix Technovation Pvt Ltd signed a license agreement with Jupiter Wellness for the distribution and sale of the company’s Photocil product in 31 countries, including the Indian market. Its commercial launch is expected to start in the first quarter of 2023.
Dr. Glynn Wilson, Chief Scientific Officer of Jupiter Wellness, said: “We are excited to visit India, home to some of our current licensing partners, and a region of great interest to us as we continue to expand our reach into global markets. international. .”
About Jupiter Wellness
Jupiter Wellness is a diversified company that supports health and wellness through the research and development of over-the-counter (OTC) products and intellectual property. The Company’s product portfolio addresses a variety of conditions, including hair loss, eczema, burns and sexual wellness. Revenue is generated through sales of OTC and consumer products, contract research agreements, and license royalties.
Investors and interested shareholders are encouraged to sign up for press releases and industry updates by signing up for email alerts at https://jupiterwellness.com/email-alerts/ and following Jupiter Wellness on Twitter Y LinkedIn.
Email: [email protected]
Contact for investors
Email: [email protected]
This release contains forward-looking statements regarding Jupiter Wellness, including the anticipated timing of the studies and the results and benefits of the studies. In general, you can identify forward-looking statements by using forward-looking terminology such as “anticipate”, “believe”, “continue”, “may”, “estimate”, “expect”, “explore”, “assess”, “intend” , “may”, “could”, “plan”, “potential”, “predict”, “project”, “seek”, “should” or “will”, or the negative thereof or other variations thereof or comparable terminology. These forward-looking statements are based on each of the Company’s current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties, many of which are beyond the control of Jupiter Wellness. Actual results and timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties and other risks and uncertainties affecting Jupiter Wellness, including those described from time to time under the heading “Risk Factors.” and elsewhere in Jupiter Wellness Securities and Exchange Commission (SEC) filings and reports, including Jupiter Wellness Annual Report on Form 10-K for the year ended December 31, 2021, and future presentations and reports from Jupiter Wellness. In addition, other risks and uncertainties of which the combined company is not currently aware may also affect each of the companies’ forward-looking statements and may cause actual results and timing of events to differ materially from those anticipated. Investors are cautioned that forward-looking statements are not guarantees of future performance. The forward-looking statements made in this release are made only as of the date hereof or the dates indicated in the forward-looking statements and reflect the views expressed therein regarding future events on such dates, even if made later. available by Jupiter Wellness on its website or otherwise. Jupiter Wellness undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date any forward-looking statements are made.
FONT: Jupiter Wellness Inc.